General Information of Disease (ID: DIS01GPL)

Disease Name Grass pollen hypersensitivity
Disease Class 4B07: Acquired lymphocytosis
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DIS01GPL: Grass pollen hypersensitivity
ICD Code
ICD-11
ICD-11: 4B07
ICD-10
ICD-10: D72.8

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Oralair grasses DMUUHK4 Approved NA [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Peptide p277 DMFFUBQ Phase 3 NA [2]
Quattro DMY4MJL Phase 3 NA [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
2 The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice. J Autoimmun. 2015 May;59:61-6.
3 Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis. Hum Vaccin Immunother. 2013 Jul;9(7):1523-31.